Moving into 2024, more hospices see joint ventures or similar partnerships to be a major growth engine. Nearly half of 143 respondents to Hospice News’ 2024 Outlook Survey, conducted with Homecare Homebase, said that joint ventures and partnerships were the growth tactics they planned to pursue the most this year. More than 62% of the […]
As Contessa Health pioneers a growing value-based palliative care-at-home program, they’ve encountered some learning curves when it comes to operating within a new payment system. Contessa is a subsidiary of Amedisys (NASDAQ: AMED), which the home health and hospice provider acquired in 2021 for $250 million. Contessa’s specialty is high-acuity care in the home, including […]
Private equity firms typically turn around and sell an asset within three to five years post-acquisition. However, some may slow that cycle down in today’s economic environment. The presence of private equity firms in the hospice arena has expanded exponentially during the past several years. But this year, deal volume slowed across the board. While […]
A rich mix of hospice merger and acquisition (M&A) activity at the end of 2023 is fueling trends into next year. Hospice M&A activity has diverged from the frenzied pace set in recent years. The hospice space in the last five years has seen record-breaking multiples, a prevalence of private equity-backed platform transactions and large-scale […]
Optum Health’s home-based care acquisitions are designed to support an overarching goal of expanding value-based care and diversifying clinical capabilities. The UnitedHealth Group (NYSE: UNH) subsidiary in June penned an agreement to acquire Amedisys in an all-cash transaction of $101 per share, or about $3.3 billion. This followed its $5.4 billion acquisition of LHC Group, […]
Investment trends in the hospice industry have meandered in recent years, impacting providers’ approaches to growth in 2024. The mix of hospice buyers has become more diverse during the past five years to include more private equity investors, large health and hospital systems and home health companies, along with payers. These trends will have lasting […]
As Amedisys Inc. (NASDAQ) awaits the outcome of its pending acquisition by Optum, the company showed only modest gains in its hospice segment. Both admissions and average daily hospice census were down in the third quarter of the year, 6% and 2%, respectively, compared to Q3 2022. Net service revenue for the segment reached slightly […]
UnitedHealth Group (NYSE: UNH) is leveraging its subsidiary Optum to drive growth in value-based care arrangements, with building out its home-based care capabilities as a high priority. This drive is evidenced by Optum’s pending acquisition of Amedisys (NASDAQ: AMED) and its purchase of home health and hospice provider LHC Group, which closed in February. By […]
Sen. Elizabeth Warren (D-Massachusetts) and Rep. Pramila Jayapal (D-Washington) have called on the U.S. Justice Department (DOJ) and the Federal Trade Commission (FTC) to “scrutinize” the pending acquisition of Amedisys (NASDAQ: AMED) by Optum Health. Optum, a subsidiary of UnitedHealth Group (NYSE: UHN), in June penned its agreement to acquire Amedisys in an all-cash transaction […]
Shareholders of Amedisys Inc. (NASDAQ: AMED) have voted in favor of the company’s pending acquisition by the UnitedHealth Group (NYSE: UNH) subsidiary Optum. Optum in June penned a deal to acquire Amedisys in an all-cash transaction of $101 per share, or about $3.3 billion. The transaction followed a previous offer to acquire Amedisys by the […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
